SCHEMBL6186796

SCHEMBL6186796

CCCc1cc(CCC=O)cc(CCC)c1OC(C(=O)O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.65
PPARA Q07869 19/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6185883 0.92 PPARG (0.60) PPARGPPARA
SCHEMBL6185879 0.91 PPARG (0.67) PPARGPPARA
SCHEMBL6186398 0.88 PPARG (0.52) PPARGPPARA
SCHEMBL7445885 0.85 PPARG (0.71) PPARGPPARA
SCHEMBL6185520 0.83 PPARG (0.67) PPARGPPARA
SCHEMBL7332649 0.81 PPARA (0.81) PPARGPPARA
SCHEMBL4017498 0.79 PPARA (1.00) PPARGPPARA
SCHEMBL2568273 0.79 PPARG (0.62) PPARGPPARA
SCHEMBL7342317 0.78 PPARA (1.00) PPARGPPARA
SCHEMBL18644977 0.78 PPARA (1.00) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1366012-A4 2-ARYLOXY-2-ARYLALKANOIC ACIDS FOR DIABETES AND LIPID DISORDERS MERCK & CO INC (US) 2005-11-02 EP claimed
EP-1366012-A2 2-ARYLOXY-2-ARYLALKANOIC ACIDS FOR DIABETES AND LIPID DISORDERS Merck & Co., Inc. (US) 2003-12-03 EP claimed
WO-2002064094-A2 2-ARYLOXY-2-ARYLALKANOIC ACIDS FOR DIABETES AND LIPID DISORDERS MERCK & CO., INC. (US) 2002-08-22 WO claimed